NVLX "its contractor, Inno Biologics Sdn. Bhd., is using the Clone-Pix(TM) technology for the isolation and selection of clones preparatory to obtaining the large numbers of cells for Nuvilex's future clinical trials in advanced, inoperable pancreatic cancer."